stockportfolio.pro
Roivant Sciences Ltd. Revenue 2021–2026
Roivant Sciences Ltd. (ROIV) annual revenue by fiscal year, computed from SEC filings. Compound growth -19.1%/yr over 5 years.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2026 | $8.26M | -71.6% |
| FY 2025 | $29.05M | -76.7% |
| FY 2024 | $124.80M | +103.6% |
| FY 2023 | $61.28M | +10.8% |
| FY 2022 | $55.29M | +132.3% |
| FY 2021 | $23.80M | — |
Source: Roivant Sciences Ltd. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Roivant Sciences Ltd.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeRoivant Sciences Ltd. — frequently asked questions
What is Roivant Sciences Ltd.'s revenue?
Roivant Sciences Ltd. (ROIV) reported revenue of $8.26M for fiscal year 2026, per its SEC filings.
How has Roivant Sciences Ltd.'s revenue changed over time?
Between fiscal 2021 and 2026, ROIV's revenue declined at roughly 19.1% per year (compound annual rate), from $23.80M to $8.26M.
Where does this data come from?
Figures are computed from Roivant Sciences Ltd.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.